Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer.

Advancements in thoracic surgery and robotic-assisted procedures enable cardiothoracic surgeons to improve the treatment of ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

This data supports the potential use of RTNova to target every metastatic site in multiple oncology indications including metastatic lung cancer. RTNova is uniquely ... By incorporating enveloped ...

On the wall of Dian Yang's office hangs a painting of a "Pandora's box of cancer" being opened with a molecular key. From ...

The study also showed that the RNA in the COVID-19 virus could incite the production of new immune cells that target and ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

“We didn’t know if it was real ... tumors by 60% to 70% in mice with human cancers including breast, colon, lung, and melanoma. More studies are needed to confirm whether the cells have the ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Genprex (GNPX) announced it has entered into an exclusive license agreement with the University of Michigan, granting Genprex a worldwide, ...

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer ...

Researchers have discovered that the Covid-19 virus can trigger the immune system to attack cancer cells. The virus's RNA ...